MARKET

PMCB

PMCB

Pharmacyte Biotech Inc
NASDAQ
1.050
-0.060
-5.40%
Opening 09:49 05/12 EDT
OPEN
1.060
PREV CLOSE
1.110
HIGH
1.170
LOW
1.050
VOLUME
6.89K
TURNOVER
--
52 WEEK HIGH
2.423
52 WEEK LOW
1.030
MARKET CAP
7.21M
P/E (TTM)
0.9517
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at PMCB last week (0505-0509)?
Weekly Report · 4h ago
Weekly Report: what happened at PMCB last week (0428-0502)?
Weekly Report · 05/05 10:10
Weekly Report: what happened at PMCB last week (0421-0425)?
Weekly Report · 04/28 10:15
Weekly Report: what happened at PMCB last week (0414-0418)?
Weekly Report · 04/21 10:15
Weekly Report: what happened at PMCB last week (0407-0411)?
Weekly Report · 04/14 10:09
Pharmaceutical Biotech, Inc. 10-Q
Press release · 04/07 10:41
Weekly Report: what happened at PMCB last week (0331-0404)?
Weekly Report · 04/07 10:09
Weekly Report: what happened at PMCB last week (0324-0328)?
Weekly Report · 03/31 10:15
More
About PMCB
PharmaCyte Biotech, Inc. is a biotechnology company. It is focused on developing cellular therapies for cancer, diabetes, and malignant ascites based upon a cellulose-based live cell encapsulation technology known as Cell-in-a-Box. Its product candidate is referred to as CypCaps. The Cell-in-a-Box encapsulation technology potentially enables genetically engineered live human cells to be used to produce various biologically active molecules. It is advancing clinical research and development of new cellular-based therapies in oncology and diabetes. It is also focused on developing therapies for pancreatic and other solid cancerous tumors by using genetically engineered live human cells. Its product candidate for the treatment of diabetes consists of encapsulated genetically modified insulin-producing cells. It is also focused on the benefits of the Cell-in-a-Box technology to develop therapies for cancer that involve prodrugs based upon certain constituents of the Cannabis plant.

Webull offers Pharmacyte Biotech Inc stock information, including NASDAQ: PMCB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PMCB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PMCB stock methods without spending real money on the virtual paper trading platform.